VivoSim Labs, INC. SEC filings VIVS
VivoSim Labs, INC. has 819 filings in SEC EDGAR's recent list, going back to Aug 4, 2010. Its latest annual report, Form ARS, was filed on Aug 21, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (material agreement). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Feb 11, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | Feb 19, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 5, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | Feb 8, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | Feb 9, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | Feb 14, 2022 | Dec 31, 2021 |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 6, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | Feb 8, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | Feb 10, 2020 | Dec 31, 2019 |
| 10-Q | Quarterly report | Nov 7, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | Feb 7, 2019 | Dec 31, 2018 |
| 10-Q | Quarterly report | Nov 8, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 9, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | Feb 8, 2018 | Dec 31, 2017 |
| 10-Q | Quarterly report | Nov 9, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 9, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | Feb 9, 2017 | Dec 31, 2016 |
| 10-Q | Quarterly report | Nov 3, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 4, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | Feb 8, 2016 | Dec 31, 2015 |
| 10-Q | Quarterly report | Nov 9, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 10, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | Feb 6, 2015 | Dec 31, 2014 |
| 10-Q | Quarterly report | Nov 7, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 8, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | Feb 6, 2014 | Dec 31, 2013 |
| 10-Q | Quarterly report | Nov 8, 2013 | Sep 30, 2013 |
| 10-Q | Quarterly report | Aug 9, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | Nov 14, 2012 | Sep 30, 2012 |
| 10-Q | Quarterly report | Aug 14, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | May 15, 2012 | Mar 31, 2012 |
| 10-Q | Quarterly report | Jan 17, 2012 | Dec 31, 2011 |
| 10-Q | Quarterly report | Oct 31, 2011 | Sep 30, 2011 |
| 10-Q | Quarterly report | May 16, 2011 | Mar 31, 2011 |
Showing 46 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- VIVS (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1497253
- Former names
- ORGANOVO HOLDINGS, INC. (until Apr 23, 2025); REAL ESTATE RESTORATION & RENTAL, INC. (until Oct 31, 2011)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.